EUVIMED · CrossrefJournal
Papillomavirus Research
ISSN 2405-8521 · Elsevier BV
Latest articles
Multiple HPV infections among men who have sex with men engaged in anal cancer screening in Abuja, Nigeria
Associations between risk-perception, self-efficacy and vaccine response-efficacy and parent/guardian decision-making regarding adolescent HPV vaccination
Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection
Towards the global elimination of cervical cancer
The role of healthcare providers in HPV vaccination programs – A meeting report
School-based human papillomavirus vaccination program for increasing vaccine uptake in an underserved area in Texas
“We brought our culture here with us”: A qualitative study of perceptions of HPV vaccine and vaccine uptake among East African immigrant mothers
Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women
Viral genome integration of canine papillomavirus 16
Whole tissue cervical mapping of HPV infection: Molecular evidence for focal latent HPV infection in humans
Mega Hpv laboratories for cervical cancer control: Challenges and recommendations from a case study of Turkey
Refining our understanding of cervical neoplasia and its cellular origins
What is needed now for successful scale-up of screening?
No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study
Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls
HPV vaccination of immunocompromised hosts
Acceptability of cervical cancer screening using visual inspection among women attending a childhood immunization clinic in Uganda
Overcoming barriers in HPV vaccination and screening programs
Modulation of antigen presenting cell functions during chronic HPV infection
Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers
Effect of age-difference between heterosexual partners on risk of cervical cancer and human papillomavirus infection
The feminization of HPV: How science, politics, economics and gender norms shaped U.S. HPV vaccine implementation
HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US
Validation of the vaccine conspiracy beliefs scale
When and how often to screen for cervical cancer in three low- and middle-income countries: A cost-effectiveness analysis
Human papillomavirus 16 (HPV16) enhances tumor growth and cancer stemness of HPV-negative oral/oropharyngeal squamous cell carcinoma cells via miR-181 regulation
Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C
Performance of the Xpert HPV assay in women attending for cervical screening
Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection
Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia
EUVIMED